Close Menu

prostate cancer

Beyond the SNP

Premium

Genome-wide association studies have put forward a vast number of SNPs associated with disease. Once you have those SNPs, the search is on for the causal variant.

Genomics vs. Cancer

Premium

Recent advances in the battle against cancer have come from sequencing, microRNAs, barcode arrays, disease stratification, pathway analysis, and more.

Snippets: Mar 25, 2009

Premium

Agilent, University of Michigan, South Africa's Centre for Proteomic and Genomic Research, SimuGen

The company has given the University of Michigan mass spec tools for prostate cancer research.

Over the past week, OGT acquired protein-array maker Sense Proteomic, Aushon bought Thermo's SearchLight protein-array business, and Gentel and Eprogen allied to help drug makers identify new autoantibody biomarkers.

OGT gains technologies for biomarker identification, which could be used for therapeutic monitoring.

IP Roundup: Mar 10, 2009

Premium

Accelr8, Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Stanford University, Aperio Technologies

The company last month presented data showing that the test could be used to detect cancer, but more work is needed to refine the test so that it can distinguish between different types of malignancies.

While its revenues were down for the quarter, CombiMatrix's full-year revenues increased 5 percent. The firm cautioned, however, that it only has enough cash to fund operations until September.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.